Top Markets
Coin of the day
InDex Pharmaceuticals Holding AB (publ) InDex Pharmaceuticals Holding AB (publ)

InDex Pharmaceuticals Holding AB (publ)

INDEX
Clasificación en acciones #28997
InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to... InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to developing therapeutic solutions for patients affected by ulcerative colitis. The company's flagship drug candidate, Cobitolimod, is presently in Phase III clinical trials, targeting the treatment of moderate to severe ulcerative colitis. Furthermore, InDex is progressing a pipeline of other DNA-based immunomodulatory sequences, which are in the preclinical phase, designed to address various immunological conditions. This enterprise was established in 2000 and operates from its headquarters in Solna, Sweden.
Precio por acción
$0.04406501
Última sincronización: 2024-07-09
Capitalización bursátil
$23.47M
Cambio (1 día)
-0.48%
Cambio (1 año)
0.00%
País
SE
Comercio InDex Pharmaceuticals Holding AB (publ) (INDEX)

Categoría

Historial de desdoblamientos de acciones de InDex Pharmaceuticals Holding AB (publ) (INDEX)
La acción InDex Pharmaceuticals Holding AB (publ) (símbolo: INDEX) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 19, 2026.
Una acción INDEX comprada antes de Aug 19, 2026 equivaldría hoy a 0 acciones INDEX.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH